PROCEDURAL CALENDAR MONITOR
DEA Cannabis Hearing Calendar
Monitor DEA hearing-related milestones, Federal Register updates, procedural deadlines, and market implications tied to federal cannabis rescheduling.
Research and monitoring only. No brokerage, trade execution, cannabis sales, or personalized financial advice.
Current Calendar Status
Operational status is refreshed from the same federal-rescheduling snapshot as the Schedule III Tracker. Educational sections below remain static monitoring context — not an official government calendar.
- Current phase
- Post-hearing briefing
- Hearing
- Concluded
- Briefing
- Deadline passed August 17, 2026 — awaiting confirmation
- Calendar focus
- Hearings, procedural deadlines, Federal Register updates
- Market relevance
- MSOS sentiment, liquidity, breadth, and U.S. operator positioning
- Last updated
- Sep 8, 2026, 9:39 PM UTC
Current unresolved event
August 17, 2026
Post-hearing briefs / transcript corrections due August 17
Deadline passed; awaiting filing/closure confirmation.
Next major step
Date not yet confirmed
ALJ recommended decision
The Administrative Law Judge issues a recommended decision for the DEA Administrator. Recommendations are not final agency action.
Recent procedural updates
- DEA ALJ administrative hearing concluded
- Agency statement on federal rescheduling
- DEA ALJ administrative hearing concluded · July 15, 2026
- Federal rescheduling proposed rule · August 25, 2026
Last updated: Sep 8, 2026, 9:39 PM UTC
Key Hearing-Related Milestones
A procedural map of hearing and calendar items in the DEA rescheduling path. Status labels are derived from the shared federal-rescheduling snapshot — monitoring context, not predictions.
HHS rescheduling recommendation
CompletedThe Department of Health and Human Services scientific review and recommendation transmitted to the Drug Enforcement Administration.
Market relevance: Established the policy direction investors monitor, though the DEA retains independent rulemaking authority and timing is not fixed.
Source: DEA Judge Issues Order On Marijuana Rescheduling Hearing Transcript Corrections
DEA proposed rule / NPRM
CompletedDate: August 25, 2026
Formal federal rulemaking to evaluate cannabis scheduling under the Controlled Substances Act.
Market relevance: Rulemaking headlines often move cannabis equity sentiment before operational or tax effects are realized.
Public comment period
CompletedA formal comment window allowing stakeholders to submit written input on the proposed rule. Distinct from later post-hearing briefs.
Market relevance: Comment volume and themes can signal industry positioning and potential procedural delays without predicting outcomes.
Administrative hearing
CompletedContested rescheduling proceedings before a DEA Administrative Law Judge.
Market relevance: Hearing activity and procedural rulings are frequent sector-sentiment catalysts.
Post-hearing briefs / transcript corrections
ActivePost-hearing briefing and transcript-correction deadlines after the administrative hearing record closes.
Market relevance: Briefing deadlines mark the bridge between hearing conclusion and the ALJ recommended decision.
ALJ recommended decision
UpcomingThe Administrative Law Judge issues a recommended decision for the DEA Administrator. Recommendations are not final agency action.
Market relevance: Markets may reprice timing expectations, but a recommendation is not a final scheduling change.
DEA Administrator action
UpcomingFinal agency decision/action by the DEA Administrator following the ALJ recommendation.
Market relevance: Administrator action is the primary agency decision investors monitor for broader scheduling outcomes.
Final rule / order
UpcomingPublished final rule or order defining any federal scheduling change and its scope.
Market relevance: Scope and effective-date details matter more than headline labels for tax and institutional narratives.
Effective date
UpcomingThe date any final scheduling change takes effect for covered categories.
Market relevance: Implementation timing can diverge from headline policy moves; breadth and liquidity often reveal how markets process the change.
Judicial review / stay
UpcomingCourt challenges or stays that may affect implementation timing without guaranteeing any outcome.
Market relevance: Litigation headlines can move sentiment independently of the administrative calendar.
What Counts as a Calendar Event?
Relevant procedural items investors and researchers commonly track during DEA rescheduling.
- DEA hearing notices
- Administrative Law Judge scheduling updates
- Federal Register notices
- Public comment deadlines
- Procedural orders
- Final rule timing signals
- Implementation dates after any final rule
Why Hearing Timing Matters
Policy and market structure themes commonly monitored around procedural calendar items — without implying investment outcomes.
Headline risk
Hearing-related calendar items frequently generate policy headlines that can move cannabis equity sentiment before operational effects are clear.
Policy delay risk
Procedural milestones — hearings, extensions, or review periods — can signal whether the administrative path is advancing or pausing.
MSOS volatility
MSOS and related ETFs are common liquid proxies for U.S. cannabis policy sentiment, making them focal points around hearing calendar updates.
Cannabis equity breadth
Whether hearing headlines coincide with broader sector participation or remain isolated to a narrow set of names provides useful context.
Liquidity confirmation
Volume and liquidity shifts around procedural dates can help distinguish headline-driven moves from sustained sector engagement.
280E timing expectations
Investors often connect rescheduling milestones to Section 280E tax treatment narratives, though regulatory interpretation would still be required.
What We’re Watching
Signals and developments that help separate procedural calendar updates from market participation.
Policy calendar
DEA notices
Official agency announcements, docket updates, and hearing-related filings.
Federal Register filings
Published proposed and final rules, notices, and comment period deadlines.
Hearing schedule changes
Rescheduling, continuance, or cancellation of administrative hearing dates.
Procedural orders
Administrative rulings that advance, pause, or reshape the hearing path.
Comment and deadline updates
Extensions, reopenings, or closures of public comment windows.
Market response
MSOS price response
How liquid cannabis equity proxies react around procedural calendar items.
Breadth expansion or deterioration
Whether sector participation widens or narrows following hearing-related headlines.
Operator relative strength
Single-name performance versus ETFs as markets distribute rescheduling sentiment.
Volume and liquidity changes
Trading activity shifts that may confirm or contradict headline-driven moves.
Policy headline follow-through
Whether procedural developments sustain market attention or fade without broader participation.
Relationship to Schedule III Tracker
The DEA Hearing Calendar tracks hearing timing and procedural dates. The Schedule III Tracker explains the broader rescheduling path. Both pages share the same current process status.
Latest Weekly Review
Use the latest public issue to see how DEA procedural developments, Schedule III headlines, MSOS price action, breadth, liquidity, and cannabis sector rotation are evolving.
CannaSetups provides market research and monitoring tools only. It does not provide brokerage services, trade execution, cannabis sales, or personalized financial advice.